Sonim Technologies announces 1-for-10 reverse stock split to regain Nasdaq compliance

DNA X, Inc.

Board approved 1-for-10 reverse stock split; effective 5:00 p.m. ET on July 17, 2024.
Common stock (SONM) to commence trading on split-adjusted basis July 18, 2024; new CUSIP 83548F 309.
No fractional shares; one full share issued in lieu of any fractional share.
Split aims to increase share price to regain compliance with Nasdaq minimum bid price requirement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.